November 3, 2025 - 08:21

As the PGA Tour fall series approaches its conclusion, players are feeling the pressure with only three events remaining to secure their status for the 2026 season. This critical stretch presents a unique opportunity for golfers to solidify their positions and earn full-time status for the upcoming year.
The stakes are high as competitors vie for top finishes, which could mean the difference between a temporary exemption and a full-time spot on the prestigious tour. With each event offering valuable FedEx Cup points and prize money, the atmosphere is charged with anticipation and urgency.
Players who have struggled earlier in the season now find themselves in a race against time, while those who have performed well are looking to maintain their momentum. As the final tournaments draw near, fans can expect thrilling performances and intense competition as golfers push themselves to the limit in pursuit of their dreams. The next three weeks will be pivotal in shaping the future of many aspiring professionals in the sport.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...